Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
234.13
+12.17 (5.48%)
At close: Dec 5, 2025, 4:00 PM EST
235.00
+0.87 (0.37%)
After-hours: Dec 5, 2025, 7:58 PM EST
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $6.79 billion as of December 5, 2025. Its market cap has increased by 34.40% in one year.
Market Cap
6.79B
Enterprise Value
5.93B
1-Year Change
34.40%
Ranking
Category
Stock Price
$234.13
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $6.79B, an increase of 7,247.61%. That is a compound annual growth rate of 68.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 6.44B | 42.85% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |